The global medical simulation market is projected to reach USD 2,575.4 Million by 2022 from USD 1,284.0 Million in 2017, at a CAGR of 14.9%. The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the market.

The report analyzes the global Market by product and service, end user, and region. On the basis of product and services, the anatomical models segment accounted for the largest share of the global market in 2016. The large share of this segment is due to high adoption of high fidelity (degree of realism) products, increasing primary care services, and shortage of healthcare professionals.

The global market by end user is segmented into academic institutes, hospitals, military, and other end users. In 2016, the academic institutes segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing awareness regarding patient safety, increasing focus on minimizing medical errors, and the rising number of medical school enrollees.

Geographically, the global medical simulation market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. The ease of accessibility to technologies, well-established distribution channels, and rising number of healthcare professionals demanding hands on patient training are the major factors driving the growth of the market in North America.

More Info: 
https://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simulation-market-1156.html